array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(23) "Hill-Rom Holdings, Inc."
["slug"]=>
string(30) "191ee-us-hill-rom-holdings-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5dbb8389-4b6c-4433-bef9-172d326a4e98"
["description"]=>
string(780) "For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible."
["address_street"]=>
string(26) "130 E Randolph St Ste 1000"
["address_place"]=>
string(7) "Chicago"
["address_region"]=>
string(8) "Illinois"
["founding_date"]=>
string(10) "1915-02-28"
["website_domain"]=>
string(11) "hillrom.com"
["website_url"]=>
string(23) "https://www.hillrom.com"
["industry_codes"]=>
array(2) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
[1]=>
string(36) "Medical Equipment Rental and Leasing"
}
["employee_count"]=>
int(300)
["article_count"]=>
int(190)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(36) "Expert Ratings For Hill-Rom Holdings"
["snippet_en"]=>
string(247) "Over the past 3 months, 6 analysts have published their opinion on Hill-Rom Holdings (NYSE:HRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company 's business to predict how a stock will"
["url"]=>
string(95) "https://markets.businessinsider.com/news/stocks/expert-ratings-for-hill-rom-holdings-1030810580"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/76347745-8382-4988-bb19-4f4b3d20389e"
["source"]=>
string(19) "businessinsider.com"
["publication_date"]=>
string(10) "2021-09-20"
["categories"]=>
array(2) {
[0]=>
string(13) "Credit Rating"
[1]=>
string(12) "Stock Market"
}
}
[1]=>
array(7) {
["title_en"]=>
string(62) "What’s Next For Hill-Rom Stock After An 18% Rise In A Month?"
["snippet_en"]=>
string(302) "The stock price of Hill-Rom Holdings, best known for its hospital beds and patient mobility solutions, has seen a rise of nearly 18% over the last twenty-one trading days, and it is also up a solid 40% year-to-date. The recent rise can be attributed to reports of Baxter’s plan to acquire Hill-Rom..."
["url"]=>
string(116) "https://www.forbes.com/sites/greatspeculations/2021/08/06/whats-next-for-hill-rom-stock-after-an-18-rise-in-a-month/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5d3cbbeb-2b73-46b7-b6cc-33ef4f08d6a7"
["source"]=>
string(10) "forbes.com"
["publication_date"]=>
string(10) "2021-08-06"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(11) "Acquisition"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(46) "Hill-Rom downgraded to neutral from buy at UBS"
["snippet_en"]=>
string(243) "Hill-Rom downgraded to neutral from buy at UBS
Published: Aug. 2, 2021 at 10:08 a.m. ET
Read Next
Read Next
S&P 500 sectors’ relative strength rankings are flashing red. More On MarketWatch Tomi Kilgore is MarketWatch 's deputy investing and"
["url"]=>
string(92) "https://www.marketwatch.com/story/hill-rom-downgraded-to-neutral-from-buy-at-ubs-01627913303"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/97445259-34be-4e8f-8561-532ea119eda0"
["source"]=>
string(15) "marketwatch.com"
["publication_date"]=>
string(10) "2021-08-02"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[3]=>
array(7) {
["title_en"]=>
string(53) "Robert W. Baird Issues a Buy Rating on Hill-Rom (HRC)"
["snippet_en"]=>
string(153) "Robert W. Baird analyst Michael Polark assigned a Buy rating to Hill-Rom (HRC) on April 30 and set a price target of $115.00. The company's shares closed"
["url"]=>
string(93) "https://www.smarteranalyst.com/new-blurbs/robert-w-baird-issues-a-buy-rating-on-hill-rom-hrc/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/12c3e545-b21d-4bae-a5b5-6e190073c580"
["source"]=>
string(18) "smarteranalyst.com"
["publication_date"]=>
string(10) "2021-05-07"
["categories"]=>
array(3) {
[0]=>
string(19) "Economic Conditions"
[1]=>
string(25) "Emergency Fund & Bail Out"
[2]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(55) "Hill-Rom Ramps Up Quarterly Dividend By 9%; Shares Gain"
["snippet_en"]=>
string(146) "Shares of Hill-Rom Holdings rose almost 2.3% to close at 107.25 on March 11 after the medical technology company lifted its quarterly common stock"
["url"]=>
string(91) "https://www.smarteranalyst.com/yahoo/hill-rom-ramps-up-quarterly-dividend-by-9-shares-gain/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1f6d096c-be22-4803-82d8-9504fe0e7a6d"
["source"]=>
string(18) "smarteranalyst.com"
["publication_date"]=>
string(10) "2021-03-12"
["categories"]=>
array(3) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(29) "Hill-Rom Can Offer 15% Upside"
["snippet_en"]=>
string(171) "We believe that Hill-Rom Holdings stock (NYSE: HRC), best known for its hospital beds and patient mobility solutions, may be a good buying opportunity at the present time."
["url"]=>
string(87) "https://www.forbes.com/sites/greatspeculations/2020/11/27/hill-rom-can-offer-15-upside/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f62f1c13-2101-4a9a-a13f-48511a377552"
["source"]=>
string(10) "forbes.com"
["publication_date"]=>
string(10) "2020-11-27"
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(105) "The Zacks Analyst Blog Highlights: SL Green Realty, American Express, Hill-Rom, Invesco and LPL Financial"
["snippet_en"]=>
string(252) "For Immediate Release. Chicago, IL – January 16, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets."
["url"]=>
string(122) "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sl-green-realty-american-express-hill-rom-invesco-and"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2020-01-16"
["categories"]=>
array(3) {
[0]=>
string(19) "Green & Responsible"
[1]=>
string(12) "Stock Market"
[2]=>
string(15) "Blogs & Columns"
}
}
[7]=>
array(7) {
["title_en"]=>
string(54) "Hill-Rom (HRC) Stock Dives on Q2 Revenue Miss, Outlook"
["snippet_en"]=>
string(146) "Hill-Rom (HRC) stock is retreating on Friday afternoon following disappointing revenue for the 2016 fiscal second quarter and a downbeat forecast."
["url"]=>
string(94) "https://www.thestreet.com/markets/hill-rom-hrc-stock-dives-on-q2-revenue-miss-outlook-13551527"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/39d16025-df97-4e56-beac-cedda669f297"
["source"]=>
string(13) "thestreet.com"
["publication_date"]=>
string(10) "2016-04-29"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[8]=>
array(7) {
["title_en"]=>
string(50) "Hill-Rom Share Options (HRC) - Investing.com India"
["snippet_en"]=>
string(133) "Get free option chain data for HRC. Find Call and Put Strike Prices, Last Price, Change, Volume, and more for Hill-Rom share options."
["url"]=>
string(63) "https://in.investing.com/equities/hill-rom-holdings-inc-options"
["image_url"]=>
NULL
["source"]=>
string(13) "investing.com"
["publication_date"]=>
NULL
["categories"]=>
array(1) {
[0]=>
string(12) "Stock Market"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[1]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(13)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(11)
}
[3]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(11)
}
[4]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(9)
}
[5]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[6]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(9)
}
[8]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(6)
}
[9]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(6)
}
[10]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(5)
}
[11]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(5)
}
[12]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(5)
}
[13]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(5)
}
[14]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(4)
}
[15]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(4)
}
[16]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(4)
}
[17]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(4)
}
[18]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(3)
}
[19]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(3)
}
[20]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(3)
}
[21]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(3)
}
[22]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(3)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(3)
}
[24]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(3)
}
[25]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(2)
}
[26]=>
array(2) {
["name"]=>
string(19) "Political Influence"
["count"]=>
int(2)
}
[27]=>
array(2) {
["name"]=>
string(14) "Product Review"
["count"]=>
int(2)
}
[28]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(9) "Antitrust"
["count"]=>
int(2)
}
}
}
191ee-us-hill-rom-holdings-inc
Hill-Rom Holdings, Inc.
Location
Illinois
Founded
1915-02-28
Website
https://www.hillrom.com
Articles
190 Articles
Category
Surgical and Medical Instruments and Apparatus
Medical Equipment Rental and Leasing
Description
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Over the past 3 months, 6 analysts have published their opinion on Hill-Rom Holdings (NYSE:HRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company 's business to predict how a stock will
The stock price of Hill-Rom Holdings, best known for its hospital beds and patient mobility solutions, has seen a rise of nearly 18% over the last twenty-one trading days, and it is also up a solid 40% year-to-date. The recent rise can be attributed to reports of Baxter’s plan to acquire Hill-Rom...
Hill-Rom downgraded to neutral from buy at UBS
Published: Aug. 2, 2021 at 10:08 a.m. ET
Read Next
Read Next
S&P 500 sectors’ relative strength rankings are flashing red. More On MarketWatch Tomi Kilgore is MarketWatch 's deputy investing and
Robert W. Baird analyst Michael Polark assigned a Buy rating to Hill-Rom (HRC) on April 30 and set a price target of $115.00. The company's shares closed
We believe that Hill-Rom Holdings stock (NYSE: HRC), best known for its hospital beds and patient mobility solutions, may be a good buying opportunity at the present time.
For Immediate Release. Chicago, IL – January 16, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.